Sk Biopharmaceuticals Co., Ltd. (326030)
Market Closed
12 Jun, 06:30
KRX SM KRX SM Primary ₩
87,900. 00
-600
-0.678%
₩
10.95T Market Cap
- P/E Ratio
- Div Yield
169,104 Volume
566.84 Eps
₩ 88,500
Previous Close Want to track 326030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 492.58 | - |
| | | 434.02 | 1.74K |
| | | 434.02 | - |
| | | - | - |
| | | - | - |
| | | 267.84 | 298 |
| | | - | - |
| | | 123.44 | 123 |
| | | 87.9 | - |
| | | 46.28 | - |
| | | 184 | 86.32 |
| | | 184 | - |
| | | - | - |
326030 Earnings Reports FAQ
What is the earnings per share (EPS) for 326030?
The current EPS is 566.84.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 1,920.39%, reflecting the 326030's performance and KRX SM market conditions.
When is the next earnings release date?
Sk Biopharmaceuticals Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sk Biopharmaceuticals Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 326030 at this time, as Sk Biopharmaceuticals Co., Ltd has no recent EPS data to calculate it.
